Figure 2

Mean ± standard error changes in the total urinary symptom scores, total International Prostate Symptom Score (IPSS; A‒C), and Overactive Bladder Symptom Score (OABSS; D‒F), from baseline to day 14. (A) All patients, (B) patients with mild symptoms, (C) patients with moderate/severe symptoms, (D) all patients, (E) patients with mild symptoms, and (F) patients with moderate/severe symptoms. Analysis of covariance was used for statistical analysis of complete intraureteral stent placement vs. conventional stent placement. *P < 0.05, N.S. no significant difference.